Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
ConvaTec ( (GB:CTEC) ) has issued an announcement.
ConvaTec Group PLC has executed a share buyback program, purchasing over 1.19 million ordinary shares at an average price of 239.24 pence per share. This move is part of a larger $300 million buyback initiative announced in August 2025, aimed at optimizing the company’s capital structure and enhancing shareholder value.
The most recent analyst rating on (GB:CTEC) stock is a Buy with a £315.00 price target. To see the full list of analyst forecasts on ConvaTec stock, see the GB:CTEC Stock Forecast page.
Spark’s Take on GB:CTEC Stock
According to Spark, TipRanks’ AI Analyst, GB:CTEC is a Neutral.
ConvaTec’s strong financial performance and strategic positioning are tempered by bearish technical indicators and a high valuation. Regulatory challenges may pose risks, but the company’s innovation pipeline and operational strength support a moderately positive outlook.
To see Spark’s full report on GB:CTEC stock, click here.
More about ConvaTec
ConvaTec Group PLC operates in the medical products industry, focusing on the development and manufacturing of products for wound care, ostomy care, continence and critical care, and infusion devices. The company is dedicated to improving the lives of patients and healthcare providers through innovative medical solutions.
Average Trading Volume: 7,750,007
Technical Sentiment Signal: Hold
Current Market Cap: £4.86B
For detailed information about CTEC stock, go to TipRanks’ Stock Analysis page.